Post Caesarean Analgesia Completed Phase 3 Trials for Ropivacaine (DB00296)

IndicationStatusPhase
DBCOND0073058 (Post Caesarean Analgesia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02264821Wound Infusion vs Spinal Morphine for Post-caesarean AnalgesiaTreatment